SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-21-010743
Filing Date
2021-05-04
Accepted
2021-05-04 16:04:53
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 snbp20210430_s3.htm S-3 257206
2 EXHIBIT 5.1 ex_246350.htm EX-5.1 39824
3 EXHIBIT 23.1 ex_246148.htm EX-23.1 2528
4 b02.jpg GRAPHIC 4272
5 p01.jpg GRAPHIC 4542
  Complete submission text file 0001437749-21-010743.txt   313133
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255751 | Film No.: 21888345
SIC: 2834 Pharmaceutical Preparations